Lv6
2466 积分 2022-06-06 加入
DNA and RNA-based next-generation sequencing for companion diagnostic rearrangement detection in solid tumors
15天前
已完结
A novel intergenic (between REG3A and CTNNA2-AS1)-ALK fusion responds to alectinib in lung adenocarcinoma
1个月前
已完结
Partial Response to Crizotinib in a Lung Adenocarcinoma Patient with a Novel FBXO11 (Intergenic)-ALK (Exon 20-29) Fusion
1个月前
已完结
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
1个月前
已完结
Genomic Landscape and Clinical Impact of MTAP Loss in Driver-Positive NSCLC: Insights from a Large-Scale Real-World Chinese Cohort
1个月前
已完结
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
1个月前
已完结
Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
1个月前
已完结
Epidermal growth factor receptor double activating mutations involving both exons 19 and 21 exist in Chinese non-small cell lung cancer patients
1个月前
已完结
A Review of Congenital Internal Abdominal Hernias
2个月前
已关闭
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors
3个月前
已完结
皖公网安备34019202002308
